Adverse Reactions of Monobenzone
Monobenzone is a depigmenting agent. It works by increasing elimination of melanin (pigment molecules) from skin cells.
Apr 7,2022 Chemical ReagentsPolyglutamic acid skin benefits
Glutamic acid is an amino acid. Polyglutamic acid is created when lots of glutamic acid molecules are linked together," says Wong. "It's produced by bacterial fermentation and is found in Nattō." [Ed
Apr 7,2022 Biochemical EngineeringFunction of Coenzyme Q10
Coenzyme Q10 (CoQ10) is a substance that is naturally present in the human body, with the highest levels in the heart, liver, kidneys, and pancreas. It is sold in the United States as a dietary supple
Apr 7,2022 Biochemical EngineeringUses and side effects of Telbivudine
Telbivudine (b-L-2u-deoxythymidine) is the unmodified b-L-enantiomer of the natural nucleoside D-thymidine. This nucleoside analog is a potent inhibitor of the replication of hepadnaviruses, including
Apr 6,2022 APIAdverse effects of Adefovir dipivoxil
Adefovir dipivoxil is a white to off-white crystalline powder with an intrinsic aqueous solubility in water of 19 mg/ml at pH 2 and 0.4 mg/ml at pH 7.2.
Apr 6,2022 APIMechanism of action of Entecavir
Entecavir (BMS-200475) is a guanosine nucleoside analog with selective activity against hepatitis B virus (HBV), as well as some activity toward HIV. It is marketed as Baracludes, and received regulat
Apr 6,2022 APIUses and Side effects of Elvitegravir
Elvitegravir (brand name Vitekta) is a drug used as part of antiretroviral therapy (ART). The FDA approved elvitegravir in 2012 as an antiretroviral drug (ARV) for people with HIV infection. Elvitegra
Apr 2,2022 APISide effects of Maraviroc
Maraviroc was synthesized by Pfizer Inc as UK-427,857 (4, 4-difluoro- N-[(1S)-3-[exo-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[ 3.2.1]oct-8-yl]-1-phenylpropyl]cyclohexanecarboxamide)
Apr 2,2022 APISide effects of Enfuvirtide
Enfuvirtide is an antiretroviral drug used in salvage regimens in (usually) highly drug-experienced individuals that suppresses replication of HIV-1 strains with multidrug resistance to reverse transc
Apr 2,2022 APIMechanism of action of Tipranavir
Tipranavir (formerly known as PNU-140690) is the first of a new class of nonpeptide protease inhibitors, the dihydropyrone sulfonamides. Tipranavir was developed and is marketed by Boehringer Ingelhei
Apr 2,2022 API












